Table 1.
. Demographics of patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
| SARS-CoV-2 infection (n = 200) | |
|---|---|
| Demographics | |
| Age, y, median (IQR) | 40.6 (30.2–51.7) |
| Male sex, n (%) | 58 (29.0) |
| Ethnicity, n (%) | |
| Caucasian | 163 (81.5) |
| Hispanic | 13 (6.5) |
| Mixed | 8 (4.0) |
| African | 6 (3.0) |
| Asian | 4 (2.0) |
| Others | 2 (1.0) |
| Not provided | 4 (2.0) |
| Comorbidities, n (%) | |
| Obesity (BMI ≥30) | 23 (11.5) |
| Asthma | 17 (8.5) |
| Hypertension | 9 (4.5) |
| Cancera | 7 (3.5) |
| Autoimmune diseaseb | 6 (3.0) |
| Diabetes | 3 (1.5) |
| Chronic lung diseasec | 3 (1.5) |
| Eczema | 3 (1.5) |
| Inflammatory bowel disease | 2 (1.0) |
| Hepatic disease | 2 (1.0) |
| Primary immune deficiency | 1 (0.5) |
| Othersd | 4 (2.0) |
| No past medical history | 140 (70.0) |
| Habits, n (%) | |
| Smoking | 23 (11.5) |
| Vaping | 9 (4.5) |
| Neither smoking nor vaping | 173 (86.5) |
BMI, body mass index; IQR, interquartile range.
a
Solid tumour (n = 5); leukaemia (n = 1); melanoma (n = 1).
b
Psoriasis (n = 2), hyperthydoidism (n = 1); hypothyroidism (n = 1); lupus (n = 1), ankylosing spondylitis (n = 1).
c
Chronic obstructive pulmonary disease (n = 1); emphysema (n = 1); pulmonary sarcoidosis (n = 1).
d
Endometriosis (n = 2); obstructive apnoea (n = 1); pacemaker (n = 1).